Tiziana Life Sciences
TLSA
4 hedge funds and large institutions have $4.64M invested in Tiziana Life Sciences in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
19% more capital invested
Capital invested by funds: $3.89M → $4.64M (+$757K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.05% less ownership
Funds ownership: 2.25% → 2.2% (-0.05%)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
+$7.76K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$637 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$80K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$3.58K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
HighTower Advisors
Chicago,
Illinois
| $4.25M | -$3.58K | -2,249 | -0.1% |
|
|
HAG
2
HighPoint Advisor Group
Downers Grove,
Illinois
| $392K | +$7.76K | +4,873 | +10% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1K | +$637 | +400 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| – | -$80K | -65,924 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$9K | -7,552 | Closed |
|
TLSA Hedge Fund Activity: Q2 2019 in Review
4 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q2 2019, worth a combined $4.64M — up 19% from $3.89M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TLSA and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was HighPoint Advisor Group, adding an estimated $7.76K. The largest seller was Citadel Advisors, exiting entirely with an estimated $80K sold.
- 4 institutional investors held Tiziana Life Sciences (TLSA) as of Q2 2019, down from 5 in Q1 2019.
- Funds reported $4.64M of Tiziana Life Sciences stock for Q2 2019, up 19% quarter-over-quarter.
- 1 fund opened new Tiziana Life Sciences positions in Q2 2019 and 2 closed out, a net change of -1 holder.
- The largest Tiziana Life Sciences buyer in Q2 2019 was HighPoint Advisor Group, an estimated $7.76K added.
- The largest Tiziana Life Sciences seller in Q2 2019 was Citadel Advisors, an estimated $80K sold.
Based on aggregated 13F filings for Q2 2019.